Global Inactivated Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 93
Published Date: 10 Jan 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
According to our (Global Info Research) latest study, the global Inactivated Polio Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Inactivated Polio Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Inactivated Polio Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Inactivated Polio Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Inactivated Polio Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Inactivated Polio Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inactivated Polio Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inactivated Polio Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute and Tiantan Biological, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Inactivated Polio Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Government
Private Sector
Market segment by Application
Pediatrics
Adults
Major players covered
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inactivated Polio Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inactivated Polio Vaccine, with price, sales, revenue and global market share of Inactivated Polio Vaccine from 2018 to 2023.
Chapter 3, the Inactivated Polio Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inactivated Polio Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Inactivated Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inactivated Polio Vaccine.
Chapter 14 and 15, to describe Inactivated Polio Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Inactivated Polio Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Inactivated Polio Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Government
1.3.3 Private Sector
1.4 Market Analysis by Application
1.4.1 Overview: Global Inactivated Polio Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pediatrics
1.4.3 Adults
1.5 Global Inactivated Polio Vaccine Market Size & Forecast
1.5.1 Global Inactivated Polio Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Inactivated Polio Vaccine Sales Quantity (2018-2029)
1.5.3 Global Inactivated Polio Vaccine Average Price (2018-2029)
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Inactivated Polio Vaccine Product and Services
2.1.4 Sanofi Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Inactivated Polio Vaccine Product and Services
2.2.4 GSK Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Inactivated Polio Vaccine Product and Services
2.3.4 Bibcol Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bibcol Recent Developments/Updates
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Inactivated Polio Vaccine Product and Services
2.4.4 Serum Institute Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Serum Institute Recent Developments/Updates
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Inactivated Polio Vaccine Product and Services
2.5.4 Tiantan Biological Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Tiantan Biological Recent Developments/Updates
2.6 Panacea Biotec
2.6.1 Panacea Biotec Details
2.6.2 Panacea Biotec Major Business
2.6.3 Panacea Biotec Inactivated Polio Vaccine Product and Services
2.6.4 Panacea Biotec Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Panacea Biotec Recent Developments/Updates
2.7 Bio-Med
2.7.1 Bio-Med Details
2.7.2 Bio-Med Major Business
2.7.3 Bio-Med Inactivated Polio Vaccine Product and Services
2.7.4 Bio-Med Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio-Med Recent Developments/Updates
2.8 Halfkin Bio-Pharmaceuticals
2.8.1 Halfkin Bio-Pharmaceuticals Details
2.8.2 Halfkin Bio-Pharmaceuticals Major Business
2.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
2.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
3.1 Global Inactivated Polio Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Inactivated Polio Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Inactivated Polio Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Inactivated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Inactivated Polio Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Inactivated Polio Vaccine Manufacturer Market Share in 2022
3.5 Inactivated Polio Vaccine Market: Overall Company Footprint Analysis
3.5.1 Inactivated Polio Vaccine Market: Region Footprint
3.5.2 Inactivated Polio Vaccine Market: Company Product Type Footprint
3.5.3 Inactivated Polio Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Inactivated Polio Vaccine Market Size by Region
4.1.1 Global Inactivated Polio Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Inactivated Polio Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Inactivated Polio Vaccine Average Price by Region (2018-2029)
4.2 North America Inactivated Polio Vaccine Consumption Value (2018-2029)
4.3 Europe Inactivated Polio Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Inactivated Polio Vaccine Consumption Value (2018-2029)
4.5 South America Inactivated Polio Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Inactivated Polio Vaccine Consumption Value (2018-2029)
5.1 Global Inactivated Polio Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Inactivated Polio Vaccine Consumption Value by Type (2018-2029)
5.3 Global Inactivated Polio Vaccine Average Price by Type (2018-2029)
6.1 Global Inactivated Polio Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Inactivated Polio Vaccine Consumption Value by Application (2018-2029)
6.3 Global Inactivated Polio Vaccine Average Price by Application (2018-2029)
7.1 North America Inactivated Polio Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Inactivated Polio Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Inactivated Polio Vaccine Market Size by Country
7.3.1 North America Inactivated Polio Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Inactivated Polio Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Inactivated Polio Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Inactivated Polio Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Inactivated Polio Vaccine Market Size by Country
8.3.1 Europe Inactivated Polio Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Inactivated Polio Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Inactivated Polio Vaccine Market Size by Region
9.3.1 Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Inactivated Polio Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Inactivated Polio Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Inactivated Polio Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Inactivated Polio Vaccine Market Size by Country
10.3.1 South America Inactivated Polio Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Inactivated Polio Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Inactivated Polio Vaccine Market Size by Country
11.3.1 Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Inactivated Polio Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Inactivated Polio Vaccine Market Drivers
12.2 Inactivated Polio Vaccine Market Restraints
12.3 Inactivated Polio Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Inactivated Polio Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Inactivated Polio Vaccine
13.3 Inactivated Polio Vaccine Production Process
13.4 Inactivated Polio Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Inactivated Polio Vaccine Typical Distributors
14.3 Inactivated Polio Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Inactivated Polio Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Inactivated Polio Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Inactivated Polio Vaccine Product and Services
Table 6. Sanofi Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Inactivated Polio Vaccine Product and Services
Table 11. GSK Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Bibcol Basic Information, Manufacturing Base and Competitors
Table 14. Bibcol Major Business
Table 15. Bibcol Inactivated Polio Vaccine Product and Services
Table 16. Bibcol Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bibcol Recent Developments/Updates
Table 18. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 19. Serum Institute Major Business
Table 20. Serum Institute Inactivated Polio Vaccine Product and Services
Table 21. Serum Institute Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Serum Institute Recent Developments/Updates
Table 23. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 24. Tiantan Biological Major Business
Table 25. Tiantan Biological Inactivated Polio Vaccine Product and Services
Table 26. Tiantan Biological Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Tiantan Biological Recent Developments/Updates
Table 28. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 29. Panacea Biotec Major Business
Table 30. Panacea Biotec Inactivated Polio Vaccine Product and Services
Table 31. Panacea Biotec Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Panacea Biotec Recent Developments/Updates
Table 33. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 34. Bio-Med Major Business
Table 35. Bio-Med Inactivated Polio Vaccine Product and Services
Table 36. Bio-Med Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bio-Med Recent Developments/Updates
Table 38. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Halfkin Bio-Pharmaceuticals Major Business
Table 40. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
Table 41. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 43. Global Inactivated Polio Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Dose)
Table 44. Global Inactivated Polio Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Inactivated Polio Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 46. Market Position of Manufacturers in Inactivated Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Inactivated Polio Vaccine Production Site of Key Manufacturer
Table 48. Inactivated Polio Vaccine Market: Company Product Type Footprint
Table 49. Inactivated Polio Vaccine Market: Company Product Application Footprint
Table 50. Inactivated Polio Vaccine New Market Entrants and Barriers to Market Entry
Table 51. Inactivated Polio Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Inactivated Polio Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
Table 53. Global Inactivated Polio Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
Table 54. Global Inactivated Polio Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Inactivated Polio Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Inactivated Polio Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 57. Global Inactivated Polio Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 58. Global Inactivated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
Table 59. Global Inactivated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
Table 60. Global Inactivated Polio Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Inactivated Polio Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Inactivated Polio Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 63. Global Inactivated Polio Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 64. Global Inactivated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
Table 65. Global Inactivated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
Table 66. Global Inactivated Polio Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Inactivated Polio Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Inactivated Polio Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 69. Global Inactivated Polio Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 70. North America Inactivated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
Table 71. North America Inactivated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
Table 72. North America Inactivated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
Table 73. North America Inactivated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
Table 74. North America Inactivated Polio Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
Table 75. North America Inactivated Polio Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
Table 76. North America Inactivated Polio Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Inactivated Polio Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Inactivated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
Table 79. Europe Inactivated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
Table 80. Europe Inactivated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
Table 81. Europe Inactivated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
Table 82. Europe Inactivated Polio Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
Table 83. Europe Inactivated Polio Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
Table 84. Europe Inactivated Polio Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Inactivated Polio Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
Table 87. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
Table 88. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
Table 89. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
Table 90. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
Table 91. Asia-Pacific Inactivated Polio Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
Table 92. Asia-Pacific Inactivated Polio Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Inactivated Polio Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Inactivated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
Table 95. South America Inactivated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
Table 96. South America Inactivated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
Table 97. South America Inactivated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
Table 98. South America Inactivated Polio Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
Table 99. South America Inactivated Polio Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
Table 100. South America Inactivated Polio Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Inactivated Polio Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
Table 103. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
Table 104. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
Table 105. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
Table 106. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
Table 107. Middle East & Africa Inactivated Polio Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
Table 108. Middle East & Africa Inactivated Polio Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Inactivated Polio Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Inactivated Polio Vaccine Raw Material
Table 111. Key Manufacturers of Inactivated Polio Vaccine Raw Materials
Table 112. Inactivated Polio Vaccine Typical Distributors
Table 113. Inactivated Polio Vaccine Typical Customers
List of Figures
Figure 1. Inactivated Polio Vaccine Picture
Figure 2. Global Inactivated Polio Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Inactivated Polio Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Government Examples
Figure 5. Private Sector Examples
Figure 6. Global Inactivated Polio Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Inactivated Polio Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Pediatrics Examples
Figure 9. Adults Examples
Figure 10. Global Inactivated Polio Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Inactivated Polio Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Inactivated Polio Vaccine Sales Quantity (2018-2029) & (K Dose)
Figure 13. Global Inactivated Polio Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 14. Global Inactivated Polio Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Inactivated Polio Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Inactivated Polio Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Inactivated Polio Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Inactivated Polio Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Inactivated Polio Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Inactivated Polio Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Inactivated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Inactivated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Inactivated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Inactivated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Inactivated Polio Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Inactivated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Inactivated Polio Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Inactivated Polio Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 29. Global Inactivated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Inactivated Polio Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Inactivated Polio Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 32. North America Inactivated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Inactivated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Inactivated Polio Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Inactivated Polio Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Inactivated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Inactivated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Inactivated Polio Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Inactivated Polio Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Inactivated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Inactivated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Inactivated Polio Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Inactivated Polio Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Inactivated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Inactivated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Inactivated Polio Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Inactivated Polio Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Inactivated Polio Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Inactivated Polio Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Inactivated Polio Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Inactivated Polio Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Inactivated Polio Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Inactivated Polio Vaccine Market Drivers
Figure 73. Inactivated Polio Vaccine Market Restraints
Figure 74. Inactivated Polio Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Inactivated Polio Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Inactivated Polio Vaccine
Figure 78. Inactivated Polio Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi GSK Bibcol Serum Institute Tiantan Biological Panacea Biotec Bio-Med Halfkin Bio-Pharmaceuticals
Related Reports
01 Apr 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
